Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Frequently asked questions
What sector does Ampio Pharm (AMPE) operate in?
Ampio Pharm belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Ampio Pharm (AMPE) current stock price?
As of the latest data, Ampio Pharm stock price is $0.18, with a previous close of $0.18.
What is Ampio Pharm (AMPE) current market capitalization?
Ampio Pharm market cap is approximately 207.88 thousand.
What is Ampio Pharm (AMPE) Earnings Per Share (EPS)?
The trailing EPS is -$12.79.
Does Ampio Pharm (AMPE) pay dividends?
No. Ampio Pharm does not pay a dividend.
What is Ampio Pharm (AMPE) beta (volatility) score?
Ampio Pharm has a beta of 17.049, indicating very high volatility compared to the market.